Clinical trial
Combination Chemotherapy in Treating Women Who Have Undergone Surgery for…
NCT00093795 · NSABP Foundation Inc, Other · Completed
Key facts
| NCT number | NCT00093795 |
|---|---|
| Title | Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer |
| Official title | A Phase III, Adjuvant Trial Comparing Three Chemotherapy Regimens in Women With Node-Positive Breast Cancer: Docetaxel/Doxorubicin/Cyclophosphamide (TAC); Dose-Dense (DD) Doxorubicin/Cyclophosphamide Followed By DD Paclitaxel (DD AC→P); DD AC Followed By DD Paclitaxel Plus Gemcitabine (DD AC→PG) |
| Lead sponsor | NSABP Foundation Inc, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Cyclophosphamide, Docetaxel, Gemcitabine, Paclitaxel, Doxorubicin |
| Enrollment | 4,894 |
| Start date | Oct 1, 2004 |
| Primary completion | Mar 1, 2012 |
| Completion | Jun 1, 2016 |
| First posted | Oct 8, 2004 |
| Last update posted | Jan 11, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: